Excess risk of chronic physical conditions associated with depression and anxiety

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Bhattacharya, Rituparna ^a   Shen, Chan ^b   Sambamoorthi, Usha ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Anxiety; Chronic physical conditions; Depression; Obesity; Physical activity; Smoking

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY; ARTHRITIS; ARTICLE; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OSTEOPOROSIS; PHYSICAL ACTIVITY; POVERTY; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; YOUNG ADULT; ADOLESCENT; AGED; CHRONIC DISEASE; COMORBIDITY; HEART DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF REPORT;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTHRITIS; ASTHMA; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DEPRESSION; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; LIFE STYLE; MALE; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT; SMOKING;

EID: 84892420828     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-10     Document Type: Article

References (73)

1. Steptoe A. Depression and physical illness 2007, Cambridge, UK: Cambridge University Press.
2. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011, 13(1):7-23. 3181964, 21485743.
3. Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013, 74(1):31-37. 10.4088/JCP.12r07922, 23419223.
4. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003, 65(2):201-210. 10.1097/01.PSY.0000058371.50240.E3, 12651987.
5. Patten SB, Williams JV, Lavorato DH, Campbell NR, Eliasziw M, Campbell TS. Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med 2009, 71(3):273-279. 10.1097/PSY.0b013e3181988e5f, 19196807.
6. Tolea MI, Black SA, Carter-Pokras OD, Kling MA. Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women. Osteoporos Int 2007, 18(3):315-322. 10.1007/s00198-006-0242-7, 17053870.
7. Mussolino ME. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep 2005, 120(1):71-75. 1497689, 15736334.
8. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999, 159(5):484-490. 10.1001/archinte.159.5.484, 10074957.
9. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G. Depression and Osteoporosis: A Research Synthesis with Meta-Analysis. Horm Metab Res 2010, 42(7):467-482. 10.1055/s-0030-1252020, 3120042, 20455194.
10. Druss BG, Rask K, Katon WJ. Major depression, depression treatment and quality of primary medical care. Gen Hosp Psychiatry 2008, 30(1):20-25. 10.1016/j.genhosppsych.2007.08.015, 2246043, 18164936.
11. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002, 23(1):51-61. 10.1016/S0749-3797(02)00439-7, 12093424.
12. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan. Diabetes Care 2008, 31(12):2383-2390. 10.2337/dc08-0985, 2584200, 19033418.
13. Covey LS. Tobacco cessation among patients with depression. Prim Care 1999, 26(3):691-706. 10.1016/S0095-4543(05)70124-X, 10436294.
14. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997, 154(2):263-265.
15. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998, 17(1):35-46.
16. Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002, 64(5):758-766. 10.1097/01.PSY.0000031578.42041.1C, 12271106.
17. Johannessen L, Strudsholm U, Foldager L, Munk-Jørgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord 2006, 95(1):13-17.
18. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007, 62(1):31-38. 10.1016/j.jpsychores.2006.07.009, 17188118.
19. Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res 2012, 73(6):418-423. 10.1016/j.jpsychores.2012.09.018, 3499773, 23148808.
20. Dorn LD, Susman EJ, Pabst S, Huang B, Kalkwarf H, Grimes S. Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch Pediatr Adolesc Med 2008, 162(12):1181-1188. 10.1001/archpedi.162.12.1181, 2660672, 19047547.
21. Jacobs J, Andersson G, Bell J, Weinstein S, Dormans J, Gnatz S, Lane N, Puzas J, St Clair E, Yelin E. Burden of musculoskeletal diseases in the United States: Prevalence, societal, and economic cost 2008, Rosemont: American Academy of Orthopaedic Surgeons.
22. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest 2013, 144:766-777. 10.1378/chest.12-1911, 23429910.
23. Scott KM, Oakley Browne MA, McGee MA, Wells JE. Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006, 40(10):882-888.
24. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289(23):3095-3105. 10.1001/jama.289.23.3095, 12813115.
25. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, Nolen WA, Zitman FG, Beekman AT, Penninx BW. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011, 72(3):341-348. 10.4088/JCP.10m06176blu, 21294994.
26. Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord 2007, 103(1-3):113-120.
27. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry 2003, 54(3):330-337. 10.1016/S0006-3223(03)00608-5, 12893108.
28. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 2004, 65(5):634-651. quiz 730, 10.4088/JCP.v65n0507, 15163249.
29. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing 2003, 32(1):81-87. 10.1093/ageing/32.1.81, 12540353.
30. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health 1998, 88(10):1518-1522. 10.2105/AJPH.88.10.1518, 1508459, 9772855.
31. Ströhle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm 2009, 116(6):777-784. 10.1007/s00702-008-0092-x, 18726137.
32. American Diabetic Association The Cardiometabolic Risk Initiative URL: http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=60382, American Diabetic Association.
33. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health Arthritis-Risk Factors URL: http://www.cdc.gov/arthritis/basics/risk_factors.htm, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health.
34. World Health Organization- Global Alliance against Chronic Respiratory Diseases Risk Factors for Chronic Respiratory Diseases URL: http://www.who.int/gard/publications/Risk%20factors.pdf, World Health Organization- Global Alliance against Chronic Respiratory Diseases.
35. Medical Expenditure Panel Survey Data Documentation MEPS HC-129: 2007 Full Year Consolidated Data File URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h129/h129doc.pdf, Medical Expenditure Panel Survey Data Documentation.
36. Medical Expenditure Panel Survey Clinical Classification Code to ICD-9-CM Code Crosswalk URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h128/h128_icd9codes.shtml.
37. Medical Expenditure Panel Survey Data Documentation MEPS HC-113: 2007 Full Year Consolidated Data File URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h113/h113doc.pdf, Medical Expenditure Panel Survey Data Documentation.
38. National Heart, Lung and Blood Institute Overview and Planning Documents 2012 Fact Book. Disease Statisics URL: http://www.nhlbi.nih.gov/about/factbook/chapter4.htm.
39. About BMI for Adults URL: http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.
40. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ 1998, 317(7168):1318.
41. Penman AD, Johnson WD. Complementary log-log regression for the estimation of covariate-adjusted prevalence ratios in the analysis of data from cross-sectional studies. Biometrical J Biometrische Zeitschrift 2009, 51(3):433-442.
42. Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 2009, 163(5):438. 10.1001/archpediatrics.2009.31, 19414690.
43. SAS Institute, Cary, NC; RTI, Research Triangle Park, NC. In North Carolina US: SAS Institute.
44. Broadley A, Korszun A, Jones C, Frenneaux M. Arterial endothelial function is impaired in treated depression. Heart 2002, 88(5):521-523. 10.1136/heart.88.5.521, 1767404, 12381649.
45. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000, 108(1):2-8. 10.1016/S0002-9343(99)00301-0, 11059434.
46. Bhattacharjee S, Bhattacharya R, Kelley GA, Sambamoorthi U. Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 2013, 29(4):273-284. 10.1002/dmrr.2393, 23390036.
47. Cohen D. Atypical antipsychotics and new onset diabetes mellitus: an overview of the literature. Pharmacopsychiatry 2004, 37:1-11.
48. Hasnain M, Hollett B. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad Med 2012, 124(4):154.
49. Madhusoodanan S, Parida S, Jimenez C. Hyperprolactinemia associated with psychotropics-a review. Hum Psychopharm clin 2010, 25(4):281-297.
50. Vartej P, Poiana C, Vartej I. Effects of hyperprolactinemia on osteoporotic fracture in premenopausal women. Gynecol Endocrinol 2001, 15(1):43-47.
51. Player MS, Peterson LE. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 2011, 41(4):365-377. 10.2190/PM.41.4.f, 22238841.
52. Jain A, Lolak S. Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep 2009, 11(3):219-225. 10.1007/s11920-009-0034-9, 19470284.
53. Bruce TO. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep 2008, 10(3):258-264. 10.1007/s11920-008-0042-1, 18652795.
54. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan K, Nemeroff CB, Bremner JD, Carney RM, Coyne JC. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58(3):175-189. 10.1016/j.biopsych.2005.05.001, 16084838.
55. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud 2007, 44(3):457-466. 10.1016/j.ijnurstu.2006.07.013, 17007859.
56. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000, 140(4):77-83. 10.1067/mhj.2000.109981, 11011352.
57. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99(16):2192-2217. 10.1161/01.CIR.99.16.2192, 10217662.
58. Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000, 20(2):137. 10.1097/00004714-200004000-00004, 10770450.
59. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002, 90(12):1279-1283. 10.1016/S0002-9149(02)02863-1, 12480034.
60. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54:317-329. 10.1016/S0006-3223(03)00569-9, 12893107.
61. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004, 58(1):65-70. 10.1080/08039480310000824, 14985157.
62. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008, 106(3):249-255. 10.1016/j.jad.2007.07.002, 17716746.
63. Cameron OG, Abelson JL, Young EA. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol Psychiatry 2004, 56(11):875-883. 10.1016/j.biopsych.2004.08.007, 15576065.
64. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001, 57(1-3):141-152.
65. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004, 10(3):258-271. 10.1016/j.cardfail.2003.09.008, 15190537.
66. Varghese FP, Brown ES. The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians. Prim Care Companion J Clin Psychiatry 2001, 3(4):151-155. 10.4088/PCC.v03n0401, 181180, 15014598.
67. Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med 2009, 71(2):187-195. 10.1097/PSY.0b013e3181907012, 19073754.
68. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res 2009, 61(8):1018-1024.
69. Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 2004, 65:20.
70. Harris M. The role of primary health care in preventing the onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol 2008, National Preventative Health Taskforce: Canberra.
71. Rittenhouse DR, Shortell SM. The patient-centered medical home. JAMA 2009, 301(19):2038-2040. 10.1001/jama.2009.691, 19454643.
72. Druss BG, Bornemann TH. Improving health and health care for persons with serious mental illness: the window for US federal policy change. JAMA 2010, 303(19):1972-1973. 10.1001/jama.2010.615, 20483975.
73. Butler M, Kane RL, McAlpine D, Kathol RG, Fu SS, Hagedorn H, Wilt TJ. Integration of mental health/substance abuse and primary care No. 173 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 09-E003 2008, Rockville, MD: Agency for Healthcare Research and Quality.